For Great Britain healthcare professionals only
GP Notebook
diabetes on the net

This promotional hub has been developed by Bayer plc and Bayer products are discussed. Bayer has fully funded the hub and is responsible for the content, logistics and selection of speakers. OmniaMed Communications has provided editorial, marketing and logistical support. © 2023 Bayer plc

Click here for Great Britain Prescribing Information for Kerendia▼ (finerenone). Adverse Event Reporting details can be found at the bottom of the page

Upcoming events

Upcoming events

2023 dates to be announced soon

Stay connected with Bayer electronic communications about Bayer’s products, services and events, some of which may be promotional in nature, by registering at pro.bayer.co.uk

Alternatively, open your phone camera application, hold it over the QR code and tap the link that appears.

Click here for Great Britain Prescribing Information for Kerendia▼ (finerenone).
Reporting adverse events and quality complaints ▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc. If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: [email protected] Further information is available on the “contact” tab at www.bayer.co.uk.
PP-KER-GB-0348 | April 2023

This promotional hub has been developed by Bayer plc and Bayer products are discussed. Bayer has fully funded the hub and is responsible for the content, logistics and selection of speakers.
OmniaMed Communications has provided editorial, marketing and logistical support.
© 2023 Bayer plc

For Great Britain healthcare professionals only
GP Notebook

Are you a Great Britain healthcare professional?

The information is intended for Great Britain healthcare professionals only.
Please confirm below.

I confirm I am a Great Britain healthcare professional.
I confirm I am a Northern Ireland healthcare professional.
I am not a Great Britain or Northern Ireland healthcare professional.
GP Notebook

You are leaving GP Notebook

GP Notebook is not responsible for content hosted on third party websites.

Continue
Close

You are leaving diabetesonthenet.com

We are not responsible for content hosted on third party websites.
You will be directed to: https://yellowcard.mhra.gov.uk

Go back
Continue
Prescribing information for Great Britain and Northern Ireland
Adverse events should be reported. Reporting forms and information can be found at https://www.mhra.gov.uk/yellowcard (UK) or https://www.hpra.ie/homepage/about-us/report-an-issue (IRE). Adverse events should also be reported to Boehringer Ingelheim Drug Safety on 0800 328 1627 (freephone) (UK) or 01 2913960 (IRE), Fax: +44 1344 742661, or by e-mail: [email protected].


You are leaving this site.

You are now leaving https://resources.gpnotebook.com/moving-forward-in-type-2-diabetes-management-with-glp-1ras-resource-hub/.
Links to external website are provided as a resource to the viewer.
This website is neither owned or controlled by Novo Nordisk.
Novo Nordisk accepts no responsibility for the content or services of the linked site.

OK
Cancel